ASID Board
The Board of Directors, chaired by the President, has overall responsibility for the Society. The ASID Council (comprised of the SIG Chairs and representatives from other affiliated medical societies) provide strategic input to the Board. A Senior Executive Officer provides day-to-day oversight of the Society’s operation, supported by a small team.
President
Professor Joseph Doyle
FRCPA FRACP
Professor Doyle is a clinician-researcher and dual-trained infectious diseases and public health physician. He has a special interest in the epidemiology, management and prevention of blood-borne viruses and emerging infections. Joe is Professor of Infectious Diseases at The Alfred and Monash University, and Deputy Director of Disease Elimination Program at the Burnet Institute. He leads a multi-disciplinary research group focused on communicable diseases of clinical fellows, PhD students, nurses, social researchers and public health practitioners. Joe has led national and global guidelines development including for the National Clinical Evidence Taskforce and the World Health Organization. He has advised government through COVID19 response and the statutory Independent Pandemic Management Advisory Committee in Victoria. He serves on the Communicable Diseases Network of Australia and Pharmaceutical Benefits Advisory Committee of the Australian Government.
Immediate Past President
Professor Katie Flanagan
FRACP
Professor Flanagan is Head of Infectious Diseases at Launceston General Hospital, Director of the Tasmanian Vaccine Trial Centre, Clinical Professor at the University of Tasmania and Adjunct Professor at RMIT University. Katie is a member of ATAGI, and Co-Chairs the ATAGI COVID-19 Vaccine Working Group. Katie undertook her undergraduate and specialist medical training in Oxford and London. She did her PhD at Oxford studying natural immunity to malaria. She worked as Head of the Infant Immunology at the MRC Research Unit in The Gambia for seven years before relocating to Australia in 2011. She has led multiple clinical trials of novel and licensed vaccines in Africa, Europe and Australia. Her current research focuses on systems vaccinology and the role of biological sex in response to vaccination.
Honorary Secretary
Professor David Paterson
FRACP FRCPA
Professor Paterson is a tenured Professor of Medicine at the Saw Swee Hock School of Public Health and the Yong Loo Lin School of Medicine, both at the National University of Singapore. He is also an Honorary Professor at the University of Queensland. Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases), a clinical trials network comprising more than 40 hospitals across Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR). This comprises trials of antibiotics, diagnostics and prevention strategies.
Dr Rekha Pai Mangalore
FRACP
Dr Rekha Pai Mangalore is an Infectious Diseases physician with experience working across public and private sectors. Her PhD research will result in the implementation of a beta-lactam therapeutic drug monitoring program at Alfred Health, Melbourne and the development of a Bayesian software precision dosing program with an overall goal of improving precision in the management of infectious diseases. Dr Mangalore is committed to addressing the prevalence of inequity, gender and racial bias; and is an advocate for change, mentoring and supporting others, and amplifying diverse voices whenever possible. She is an Infectious Diseases Advanced trainee (RACP) supervisor and mentor; and also supports and mentors medical students, particularly those from overseas and from diverse backgrounds.
Dr Nigel Raymond
FRACP
Dr Raymond is an Infectious Diseases & General Physician at Capital & Coast (Wellington), Te Whatu Ora. He is an Honorary Clinical Senior Lecturer, University of Otago, and an IPC advisor for Evolution Healthcare, Wellington. He has chaired the New Zealand ASID Committee, 2017 – 2023. During the COVID-19 pandemic he chaired the Ministry’s COVID-19 Therapeutics technical advisory group (TAG) and was a member of the national COVID-19 TAG. He is a member of PHARMAC’s COVID-19 Treatments Advisory Group. His recent research interests include sepsis and COVID-19. Dr Raymond is an advocate for the advancement of infection services, including with the Ministry of Health and Te Whatu Ora (Health NZ) following recent NZ Health reforms.
Honorary Treasurer
Professor Chris Blyth
FRACP FRCPA
Professor Chris Blyth is a Paediatric Infectious Diseases Physician at Perth Children’s Hospital and Clinical Microbiologist with PathWest Laboratories. As director of the Wesfarmers Centre of Vaccine and Infectious Disease, Telethon Kids Institute, clinical academic at University of Western Australia and NHMRC Emerging Leadership Fellow, his research group undertakes basic, clinical and applied research focusing on the treatment and prevention of childhood infection, particularly acute respiratory infections. He has a particular interest in vaccine policy. He was a member of ATAGI from 2012 and co-chair from 2018-2021.
Associate Professor Caitlin Keighley
FRCPA FRACP
Associate Professor Caitlin Keighley is a microbiologist and infectious diseases physician, with interests in mycology, AMR, genomics and clinical education. She works at Southern.IML Pathology, and is an adjunct Associate Professor at the University of Wollongong. She is a current co-chair of the ANZMIG having been an active contributor for ten years, and is completing a PhD in mycology. She is also an active member of the Wollongong Antimicrobial Resistance Research Alliance (WARRA), a large-scale research initiative aiming to analyse trends of AMR across community and inpatient settings, and is an executive of the local human research ethics committee, which has provided insight into data governance and linkage.
Professor Ben Marais
FRACP
Professor Marais is a Paediatric Infectious Diseases Physician at the Westmead Children’s Hospital. He is also the acting Director of the Sydney Infectious Diseases Institute (Sydney ID). He held consecutive NHMRC Career Development and Practitioner Fellowships. His research focuses primarily on strategies to reduce the global tuberculosis (TB) disease burden, how children are affected by the TB pandemic and the spread of drug resistant TB. He co-leads the WHO Collaborating Centre in Tuberculosis at the University of Sydney and the NHMRC Centre for Research Excellence in Tuberculosis. He serves on the National TB Advisory Committee (NTAC) and is deputy-Chair of the WHO/STOP-TB Partnership Child and Adolescent TB working group.
Dr Candice Holland
FRACP, FAFPHM
Dr Candice Holland is a dual-trained Infectious Diseases and Public Health Physician working for West Moreton Health and Metro North Health in Brisbane, including the Queensland Statewide Syphilis Register. She held public health leadership positions with the Queensland Department of Health Communicable Diseases Branch, with contributions to responses to Communicable Diseases Incidents of National Significance for COVID-19, Japanese encephalitis virus and mpox. Dr Holland is currently Co-chair of the ASID Advocacy and Policy Committee and the National Q Fever interest group (QFIG). She has particular interest in communicable diseases prevention and control, AMR policy, vaccine preventable diseases, BBVSTIs, prisoner health, One Health and sustainable healthcare.
